Novartis Garage Sale: 1 Never Used Modular Biologicals Plant (New with tags!)

SUGAR LAND--February 4, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Once destined to be the heart of a planned $300 million Novartis AG (NYSE:NVS) (Basel, Switzerland) biological manufacturing plant in Recife, Brazil, 40 huge pods of advanced process equipment instead sit in a Charleston, South Carolina warehouse. With the Recife plan abandoned, the company is asking $35 million for the entire lot, all ready to be shipped, piped, wired and begin production. Within this article: Status of a biological manufacturing plant project by Novartis AG (NYSE:NVS).